Financial barriers and perceived implicit biases were both barriers that families of children with acute leukemia raised regarding access to care issues that might have delayed diagnosis, said Lena Winestone, MD, assistant professor of pediatrics at the University of California, San Francisco.
Financial barriers and perceived implicit biases were both barriers that families of children with acute leukemia raised regarding access to care issues that might have delayed diagnosis, said Lena Winestone, MD, assistant professor of pediatrics at the University of California, San Francisco.
Transcript
What did the interviews you conducted reveal about access to care and how it might influence disparities among children with acute leukemia?
Yeah, so in the interviews that we conducted, families identified a variety of different barriers to care. But some of the ones that really jumped out to us were the financial barriers. So, several families said that they either took longer to go to their primary care doctor, or that [financial costs] was involved in the decision making about whether they went to the primary care doctor versus an urgent care versus an emergency room. Their type of insurance and the co-pays associated with that really determined how they chose to navigate the health system and get the care that they ultimately receive. And we think that that probably has implications for the timeliness of their diagnosis.
In addition, there were some suggestions of sort of interactions between the provider and patient that were less than optimal. And we're sort of continuing to work to tease apart whether that could be related to some racial implicit bias. And, you know, some patients at least felt as if their provider treated them differently, either because of their age or because of their race, or because of their ethnicity, or because of language barriers. And so those pieces are ongoing investigation to understand exactly what barriers particularly our impoverished patients and our minority patients face.
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Redefining Long COVID Care With Personalized Treatment
March 20th 2025To mark the 5-year anniversary of the COVID pandemic, The American Journal of Managed Care® spoke with Noah Greenspan, DPT, PT, CCS, EMT-B, cardiopulmonary physical therapist and director of the Pulmonary Wellness and Rehabilitation Center in New York City.
Read More
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
STEER Data Open Door to SMA Gene Therapy for Wider Age Range of Children
March 19th 2025Delivery of onasemnogene abeparvovec into the intrathecal space was safe and effective for children with spinal muscular atrophy (SMA) aged 2 to 17 years, who had previously been shut out of receiving gene therapy.
Read More